Ajuste direto para aquisição de B770 - Bevacizumab [25 mg/ml; 100 mg/ 4 ml; conc p/a sol p/a perfusão; frs] doentes em tratamento e T1592 - Tocilizumab [162 mg/ 0.9 ml; caneta].

ID 10961727 · Portal BASE
Price
Base Price
€18,385 .00
Effective Price
€18,385 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Matosinhos
Bidder Count
1
Winner
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Company
Competition
1 bidder recorded
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Dates
Publication
10 Oct 2024
Celebration
09 Oct 2024
Contracting Entity
Unidade Local de Saúde de Matosinhos,, E.P.E.
NIF 506361390
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 20 · LOW RISK
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17